| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.2 |